HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyle M Kampman Selected Research

Cocaine-Related Disorders (Cocaine Addiction)

3/2022Varenicline for the Treatment of Cocaine Dependence.
10/2015A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
7/2014Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.
1/2014Biomarkers for the development of new medications for cocaine dependence.
1/2014The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.
6/2013Case-control association study of WLS variants in opioid and cocaine addicted populations.
11/2012Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.
10/2012A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
2/2012Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
3/2011A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyle M Kampman Research Topics

Disease

31Cocaine-Related Disorders (Cocaine Addiction)
03/2022 - 03/2002
22Alcoholism (Alcohol Abuse)
07/2021 - 01/2004
11Substance Withdrawal Syndrome (Withdrawal Symptoms)
03/2022 - 01/2002
10Substance-Related Disorders (Drug Abuse)
01/2020 - 03/2006
6Opioid-Related Disorders (Opiate Addiction)
10/2021 - 10/2010
2Infections
10/2021 - 02/2010
2Hepatitis C
10/2021 - 02/2010
2Mental Disorders (Mental Disorder)
01/2021 - 04/2010
2Sleep Initiation and Maintenance Disorders (Insomnia)
05/2019 - 06/2014
2Narcolepsy
10/2015 - 05/2003
2Heroin Dependence (Heroin Abuse)
05/2013 - 03/2012
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021
1Opiate Overdose
10/2019
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
10/2015
1Neoplasms (Cancer)
01/2014
1Movement Disorders (Movement Disorder)
03/2012
1Obesity
12/2011
1Marijuana Use
04/2008
1Marijuana Abuse (Cannabis Abuse)
04/2008

Drug/Important Bio-Agent (IBA)

25Cocaine (Cocaine HCl)IBA
03/2022 - 01/2002
13Pharmaceutical PreparationsIBA
10/2021 - 01/2002
8Naltrexone (ReVia)FDA LinkGeneric
11/2014 - 12/2006
6Dopamine (Intropin)FDA LinkGeneric
01/2020 - 10/2006
5Topiramate (Topamax)FDA LinkGeneric
07/2021 - 09/2004
4Buprenorphine (Subutex)FDA LinkGeneric
10/2021 - 10/2010
4Opioid Analgesics (Opioids)IBA
01/2021 - 10/2010
4Modafinil (Provigil)FDA Link
10/2015 - 05/2003
3Varenicline (Chantix)FDA Link
03/2022 - 02/2012
3Quetiapine Fumarate (Seroquel)FDA Link
05/2019 - 08/2007
3Amantadine (Aman)FDA LinkGeneric
09/2008 - 09/2002
3Disulfiram (Antabuse)FDA Link
05/2008 - 12/2005
2Heroin (Diamorphine)IBA
10/2019 - 03/2012
2Delayed-Action PreparationsIBA
01/2018 - 11/2014
2Dopamine Receptors (Dopamine Receptor)IBA
01/2014 - 11/2012
2Biomarkers (Surrogate Marker)IBA
01/2014 - 02/2010
2Proteins (Proteins, Gene)FDA Link
07/2013 - 11/2012
2Acamprosate (Campral)FDA Link
03/2011 - 06/2009
2EnzymesIBA
12/2008 - 03/2006
2Propranolol (Inderal)FDA LinkGeneric
09/2008 - 11/2006
2Serotonin (5 Hydroxytryptamine)IBA
10/2006 - 03/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
10/2006 - 03/2006
1Naloxone (Narcan)FDA LinkGeneric
01/2018
1Crack CocaineIBA
07/2014
1Buspirone (Buspar)FDA LinkGeneric
07/2014
1EndocannabinoidsIBA
07/2013
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
07/2013
1Opioid Receptors (Opioid Receptor)IBA
06/2013
1CalciumIBA
11/2012
1Methadone (Dolophine)FDA LinkGeneric
03/2012
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
03/2012
1Sertraline (Zoloft)FDA LinkGeneric
06/2010
1Antidepressive Agents (Antidepressants)IBA
06/2010
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2010
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
04/2010
1Dopamine D3 ReceptorsIBA
10/2009
1Nerve Growth Factors (Neurotrophins)IBA
04/2009
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
12/2008
1Psychotropic Drugs (Psychoactive Drugs)IBA
09/2008
1Amphetamine (Amfetamine)FDA LinkGeneric
08/2008
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
04/2008
1Antipsychotic Agents (Antipsychotics)IBA
08/2007
1Narcotic Antagonists (Opioid Antagonists)IBA
12/2006
1Glutamine (L-Glutamine)FDA Link
10/2006
1Tryptophan (L-Tryptophan)FDA Link
03/2006
1preproenkephalinIBA
11/2005
1N-nitrosoiminodiacetic acidIBA
03/2005
1Olanzapine (Zyprexa)FDA Link
06/2003
1Oxazepam (Serax)FDA LinkGeneric
01/2002

Therapy/Procedure

2Secondary Prevention
07/2014 - 12/2005
2Deep Brain Stimulation
03/2012 - 12/2011
1Injections
11/2014
1Drug Therapy (Chemotherapy)
09/2008